Gilad A Ofek

Univ Of Maryland, College Park

$1,245,217

Attributed

$6,162,849

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.8M · FY2022–25

$2M$1.5M$1M$500K$0

'22

'23

'24

'25

Funding mix

By agency

NIH$6,162,849 · 2

By mechanism

R01$5,737,237 · 1

UH2$425,612 · 1

Top collaborators

Most similar at Univ Of Maryland, College Park

Same institution · by research overlap

Brian G. Pierce$5,043,672
Thomas R Fuerst$2,156,141
Alexander Andrianov$2,015,325
Ian M White$6,468,344

Others in their field

Other Rising Stars on “Glycoproteins”

Robert W Cross · University Of Texas Med Br Galveston$4,640,498
Kai Xu · Ohio State University$4,531,041
Courtney Cohen · Albert Einstein College Of Medicine$3,541,248
Torben Schiffner · Vanderbilt University$3,383,634
Goran Bajic · Icahn School Of Medicine At Mount Sinai$3,116,277
Choi-Fong Cho · Brigham And Women'S Hospital$2,666,597

Research focus

GlycoproteinsAntigensMembraneAntibodiesEfficacy TestingHepatitis C VirusGenomeImmunityAnimal ModelAcute Hepatitis CFibrosisBurden Of IllnessCirrhosisHepatitis C VaccineAntigenic DiversityAntibody ResponseAmino AcidsAffinityComplexB-LymphocytesBindingBiochemicalEvaluationEpitopes

Grant awards (6)

Rational design and efficacy testing of vaccines against HCV$1,357,012

R01 · FY2025 · AI

Structural correlates of protection for antibodies targeting Marburg virus GP2$425,612

UH2 · FY2025 · AI · contact PI

Rational design and efficacy testing of vaccines against HCV$1,410,043

R01 · FY2024 · AI

Rational design and efficacy testing of vaccines against HCV$179,958

R01 · FY2024 · AI

Rational design and efficacy testing of vaccines against HCV$1,379,680

R01 · FY2023 · AI

Rational design and efficacy testing of vaccines against HCV$1,410,544

R01 · FY2022 · AI